ST Pharm Co.Ltd (237690) — Financial Flexibility Index
ST Pharm Co.Ltd (237690) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of ₩-15.27 Billion (operating CF ₩-21.16 Billion minus capex ₩5.89 Billion) represents 0% of total liabilities (₩189.56 Billion). Also explore net asset growth rate of ST Pharm Co.Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ST Pharm Co.Ltd Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for ST Pharm Co.Ltd across 11 annual periods. Check ST Pharm Co.Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ST Pharm Co.Ltd (2015–2025)
Year-by-year free cash flow to debt coverage for ST Pharm Co.Ltd. For the full company profile including market capitalisation, see market cap of ST Pharm Co.Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | ₩61.27 Billion | ₩13.99 Billion | ₩189.56 Billion | ▼ -63.3% |
| 2024 | 0.88x | ₩192.68 Billion | ₩109.45 Billion | ₩218.88 Billion | ▲ +467.7% |
| 2023 | 0.16x | ₩44.74 Billion | ₩1.30 Billion | ₩288.53 Billion | ▼ -46.6% |
| 2022 | 0.29x | ₩67.69 Billion | ₩7.03 Billion | ₩233.02 Billion | ▼ -13.6% |
| 2021 | 0.34x | ₩59.06 Billion | ₩7.27 Billion | ₩175.59 Billion | ▲ +1380.8% |
| 2020 | -0.03x | ₩-3.95 Billion | ₩-20.93 Billion | ₩150.24 Billion | ▲ +95.7% |
| 2019 | -0.61x | ₩-24.30 Billion | ₩-30.52 Billion | ₩40.12 Billion | ▼ -122.2% |
| 2018 | 2.72x | ₩37.93 Billion | ₩10.77 Billion | ₩13.94 Billion | ▲ +0.8% |
| 2017 | 2.70x | ₩82.13 Billion | ₩54.44 Billion | ₩30.42 Billion | ▲ +120.4% |
| 2016 | 1.23x | ₩66.81 Billion | ₩50.78 Billion | ₩54.53 Billion | ▲ +121.0% |
| 2015 | 0.55x | ₩58.22 Billion | ₩35.82 Billion | ₩105.04 Billion | — |